Centrally mediated abdominal pain syndrome
CAPS · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Chronic or near-continuous abdominal pain with little relation to gut function, from altered central pain processing. Diagnosed positively after excluding organic disease; managed with neuromodulators and a biopsychosocial approach rather than repeated investigation.
Red flags
- Weight loss, GI bleeding, anaemia or nocturnal symptoms
- New or changing pain pattern
- Fever or systemic features
- Escalating opioid requirement (hyperalgesia)
Assessment
Differential diagnosis
- Irritable bowel syndrome
- Chronic pancreatitis
- Abdominal wall pain (anterior cutaneous nerve entrapment)
- Narcotic bowel syndrome / opioid-induced hyperalgesia
- Mesenteric ischaemia (intermittent)
- Organic disease yet to declare
Investigations
- Focused baseline bloods (FBC, CRP, LFTs, coeliac serology) to exclude organic disease
- Faecal calprotectin where inflammation suspected
- Targeted imaging only if red flags — avoid repetitive scanning
- Carnett's test to identify abdominal wall pain
- Review opioid use (narcotic bowel syndrome)
Management
- Make a positive diagnosis using Rome criteria after reasonable exclusion of organic disease
- Assess psychosocial context, functional impact and prior investigations
- Avoid repeated, low-yield investigations that reinforce illness behaviour
- Explain the diagnosis empathetically — real pain from altered gut-brain signalling, not 'in the mind'
- Identify and withdraw opioids if narcotic bowel syndrome is present
- Start a central neuromodulator — a tricyclic antidepressant first-line
- Consider an SNRI or augmentation if tricyclics are ineffective or not tolerated
- Offer psychological therapies: cognitive behavioural therapy, gut-directed hypnotherapy
- Set functional goals rather than complete pain eradication
- Build a therapeutic alliance with a single coordinating clinician
- Review regularly, adjusting neuromodulator and reinforcing self-management
Drugs & doses
Amitriptyline 10–25 mg PO at night, titrate to 50–75 mg
Nortriptyline 10–25 mg PO at night (fewer side effects)
Duloxetine 30–60 mg PO once daily (SNRI alternative)
Avoid opioids entirely
Disposition
Outpatient gastroenterology with psychology/pain services; avoid repeat emergency presentations through continuity of care.
Complications & pitfalls
- Opioid dependence and narcotic bowel syndrome
- Iatrogenic harm from repeated investigation/surgery
- Depression, anxiety and disability
- Doctor-shopping and fragmented care
Exam pearls
- Diagnose positively — endless investigation worsens outcomes and reinforces symptoms
- Opioids cause and perpetuate pain (narcotic bowel syndrome) — withdraw them
- Neuromodulators here treat central pain processing, not depression — explain this to aid adherence
- A consistent single-clinician relationship is therapeutic in itself
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.